CLIMB BIO, INC. (CLYM) Operating cash flow 2020–2025
CLIMB BIO, INC. (CLYM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$54.4MFY2025 · since FY2020: -$14.1M → -$54.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.4M | -249.3% |
| FY2024 | -$15.6M | +24.5% |
| FY2023 | -$20.6M | +44.9% |
| FY2022 | -$37.4M | -3.6% |
| FY2021 | -$36.1M | -155.9% |
| FY2020 | -$14.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLYM financial trends
CLYM RevenueCLYM Net incomeCLYM Net marginCLYM Gross profitCLYM Gross marginCLYM Operating incomeCLYM Operating marginCLYM Free cash flowCLYM Capital expendituresCLYM Return on equityCLYM Stock buybacksCLYM Dividends paidCLYM Total assetsCLYM Total liabilitiesCLYM Shareholders’ equityCLYM overview →